| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 523 | 8.910 | 10.931 | 20.287 | 27.656 | 21.939 | 28.389 | 44.995 | 45.257 | 40.971 |
| Total Income - EUR | 532 | 8.976 | 11.178 | 21.894 | 29.529 | 23.222 | 29.323 | 45.325 | 46.091 | 40.971 |
| Total Expenses - EUR | 597 | 7.721 | 11.342 | 15.122 | 19.889 | 17.771 | 18.635 | 23.798 | 30.920 | 27.663 |
| Gross Profit/Loss - EUR | -66 | 1.255 | -164 | 6.772 | 9.641 | 5.450 | 10.689 | 21.527 | 15.171 | 13.307 |
| Net Profit/Loss - EUR | -82 | 1.051 | -275 | 6.558 | 9.371 | 5.166 | 10.689 | 21.527 | 13.107 | 11.513 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Saby Omorfi Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.188 | 4.291 | 2.880 | 10.828 | 15.730 | 10.392 | 5.232 | 3.116 | 1.093 | 4.523 |
| Current Assets | 933 | 478 | 1.639 | 4.250 | 11.449 | 13.198 | 21.129 | 40.932 | 52.283 | 56.247 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 154 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 97 | 121 | 20.581 | 49.327 | 44.361 |
| Cash | 933 | 478 | 1.639 | 4.250 | 11.449 | 13.101 | 21.008 | 20.351 | 2.802 | 11.886 |
| Shareholders Funds | -37 | 1.015 | 723 | 7.268 | 16.499 | 19.176 | 25.184 | 42.520 | 52.202 | 60.146 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.158 | 3.754 | 3.795 | 8.005 | 9.740 | 3.797 | 931 | 1.898 | 1.458 | 1.095 |
| Income in Advance | 0 | 0 | 0 | 0 | 1.170 | 812 | 465 | 137 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4933 - 4933" | |||||||||
| CAEN Financial Year |
4932
|
|||||||||
Comments - Saby Omorfi Srl